Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269659
Max Phase: Preclinical
Molecular Formula: C82H141N18O16+
Molecular Weight: 1635.14
Associated Items:
ID: ALA5269659
Max Phase: Preclinical
Molecular Formula: C82H141N18O16+
Molecular Weight: 1635.14
Associated Items:
Canonical SMILES: CC[C@](C)(NC(=O)[C@@H]1CCCCN1C(=O)C(C)(C)NC(=O)[C@@H]1CCCCN1C(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(=O)NCC(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N1CCCC[C@H]1C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)CN1CCC[N+]2=C1CCC2
Standard InChI: InChI=1S/C82H140N18O16/c1-23-82(22,93-68(109)59-34-26-29-43-100(59)74(115)80(18,19)92-66(107)57-32-24-27-41-98(57)53(9)101)73(114)95-78(14,15)71(112)88-55(45-50(4)5)64(105)83-37-36-60(102)84-47-61(103)89-79(16,17)72(113)94-81(20,21)75(116)99-42-28-25-33-58(99)67(108)91-76(10,11)69(110)85-52(8)63(104)87-56(46-51(6)7)65(106)90-77(12,13)70(111)86-54(44-49(2)3)48-97-40-31-39-96-38-30-35-62(96)97/h49-52,54-59H,23-48H2,1-22H3,(H12-,83,84,85,86,87,88,89,90,91,92,93,94,95,102,103,104,105,106,107,108,109,110,111,112,113,114)/p+1/t52-,54-,55-,56-,57-,58-,59-,82-/m0/s1
Standard InChI Key: FPFAZFRKTAPJIC-TYMATEDWSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1635.14 | Molecular Weight (Monoisotopic): 1634.0767 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Patel BA, D'Amico TL, Blagg BSJ.. (2020) Natural products and other inhibitors of F1FO ATP synthase., 207 [PMID:32942072] [10.1016/j.ejmech.2020.112779] |
Source(1):